Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.

Abstract

PURPOSE The aim of this study was to determine whether the ERCC1 expression is effective to predict the clinical outcomes of patients with advanced gastric cancer (AGC) and who were treated with cisplatin-based first-line chemotherapy. MATERIALS AND METHODS A total of 89 measurable AGC patients received cisplatin and capecitabine, with or without… (More)
DOI: 10.4143/crt.2010.42.2.101

Topics

4 Figures and Tables

Cite this paper

@article{Yun2010PredictiveVO, title={Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.}, author={Jina Yun and Kyoung-Mee Kim and Seung Tae Kim and Jung-Hoon Kim and Jung Ae Kim and Jee Hyun Kong and Soo Hyeon Lee and Young-Woong Won and Jong-mu Sun and Jeeyun Lee and Se Hoon Park and Joon Oh Park and Young Suk Park and Ho Lim and W. Kang}, journal={Cancer research and treatment : official journal of Korean Cancer Association}, year={2010}, volume={42 2}, pages={101-6} }